The government today said multi national companies (MNCs) are campaigning against domestic pharma industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment. In a written reply to the Lok Sabha, Minister of State for Commerce and Industry Jyotiraditya Scindia said: "A concerted campaign against India pharma industry has been launched by MNCs whose interests are getting adversely impacted due to increasing...

Patients battling cancer, infections and mental illness joined a rally here today beseeching the government to reject a trade pact with the European Union that they fear will threaten the availability of inexpensive generic medicines in India. An estimated 2,000 people, many among them infected with HIV, walked along Delhi’s Parliament Street on a day when Indian and EU officials were negotiating a free trade agreement in Brussels. Health activists and lawyers...

‘It will hinder access to quality, affordable generic medicines produced in India' People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations. The EU is pushing for harmful IP provisions to be included in the trade agreement...

India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India–EU Free Trade Agreement (FTA) negotiations. For instance, EU negotiators have sought India’s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate...

Said it failed to state ethical aspects involved in the study Proposal was based on the assumption that vaccine was safe and efficacious: PHFI Brinda demands compensation for all subjects victimised by vaccine programme The proposal for conducting the now controversial “Post-licensure observational study of Human Papilloma Virus (HPV) vaccination: Demonstration Project,” carried out by a non-governmental organisation PATH for two major pharmaceutical companies, had been turned down by the Public Health Foundation...